Navigation Links
Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million
Date:8/11/2008

date the forward- looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

For more information, please contact:

Kiwa Bio-Tech Products Group Corporation

Yvonne Wang

Tel: 626-715-5855

Email: kiwabiotech@gmail.com

Robert Schechter

Equity Communications

Tel: 212-499-6809

Email: ir4kiwa@hotmail.com CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(UNAUDITED)

Three Months Ended June 30, Six Months Ended June 30,

2008 2007 2008 2007

Net sales $ 3,027,497 $ 1,872,647 $ 5,211,768 $ 3,256,740

Cost of

sales 2,960,296 1,798,905 5,081,862 3,044,675

Gross profit 67,201 73,742 129,906 212,065

Operating expenses

Consulting

and

professional

fees 70,310 267,678 188,777 457,139

Officers'

compensation 59,431 89,427 118,463 154,469

General

and

administrative 229,147 196,499 474,517 375,523

Selling

expenses 66,127 63,642 114,581 207,267

Research

and

development 55,415 43,495 101,132 92,799

Depreciation

and

amortization 26,641 29,591 52,818 60,864

Allowance

and provision (2,439) 398 (58) 664

Total operating

expenses 504,632
'/>"/>

SOURCE Kiwa Bio-Tech Products Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Kiwa Bio-Tech Receives Nationally Recognized Organic Products Certification
2. Kiwa Bio-Tech Signs RMB 150 Million (US$21+ million) Fertilizer Contract
3. Kiwa Bio-Tech Receives Authorization From the Ministry of Commerce of the Peoples Republic of China to Wholesale Other Fertilizer Manufacturers Products
4. Kiwa Bio-Tech Joint Venture to Produce Preventative for Avian Flu
5. Kiwa Bio-Tech in Collaboration Discussions with Beijing Hai Xin Science and Technology Co., Ltd.
6. Kiwa Bio-Tech Passes Test & Taking Orders From Beijing Lv Fu Long Vegetable Company
7. Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd.
8. Kiwa Bio-Tech 1st Quarter Revenues Increase 57.8% - $2.18 Million
9. Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million
10. Kiwa Bio-Tech New Bio-Fertilizer Product Granted Initial Fertilizer Registration Certificate By Ministry of Agriculture of the PRC
11. Kiwa Bio-Tech Products Group Discusses Cooperative Research With the University of Waterloo, Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , ... September 04, 2015 , ... Canadian astronomer David ... observation logs he has maintained for nearly 60 years to the Linda Hall ... 9 that collided with Jupiter in 1994 — an episode that produced the first ...
(Date:9/3/2015)... ... September 03, 2015 , ... UCLA wide receiver and ... treatment and therapy were not working so Zach decided to undergo stem cell ... Zack with precisely guided injections of bone marrow aspirate concentrate (BMAC) harvested with ...
(Date:9/3/2015)... 3, 2015 According to a ... (LC (HPLC, UHPLC, Flash), GC, Other Components (Autosamplers, Detectors, ... Vials) - Analysis & Global Forecasts to 2020", published ... reach around 9.223 Billion by 2020 from USD 7.062 ... Browse 141 tables and 36 figures spread through ...
(Date:9/2/2015)... 2015 Research and Markets ( ... Jain PharmaBiotech,s new report "Nanobiotechnology Applications, ... An increasing use of ... is anticipated. Nanotechnology will be applied at ... formulations for optimal delivery to diagnostic applications ...
Breaking Biology Technology:Renowned Astronomer David Levy To Donate Night Sky Observation Logs to the Linda Hall Library 2Renowned Astronomer David Levy To Donate Night Sky Observation Logs to the Linda Hall Library 3UCLA Wide Receiver and Canadian Decathlon Standout Zack Bornstein Bounces Back After Stem Cell Therapy at Riordan-McKenna Institute 2UCLA Wide Receiver and Canadian Decathlon Standout Zack Bornstein Bounces Back After Stem Cell Therapy at Riordan-McKenna Institute 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 2Chromatography Instruments Market Worth $ 9.223 Billion by 2020 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 4Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3
... 28, 2012 Regado Biosciences, Inc., a privately held company ... announced that David J. Mazzo, PhD, President and CEO, will ... Annual Health Care Conference at 1:30 p.m. EST on March ... MA.  The presentation will include an overview ...
... ViroPharma Incorporated (Nasdaq: VPHM ) reported today its ... 31, 2011. In 2011, we: Achieved ... $251 million in net sales of Cinryze® (C1 esterase inhibitor ... Hydrochloride Capsules, USP); Attained non-GAAP adjusted net income of ...
... 28, 2012 Ultragenyx Pharmaceutical Inc., a biotechnology ... ultra-rare genetic disorders, today announced that the FDA ... drug designation for UX003 for the treatment of ... autosomal recessive lysosomal storage disorder characterized by a ...
Cached Biology Technology:Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA 2Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA 3ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 2ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 3ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 4ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 5ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 6ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 7ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 8ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 9ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 10ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 11ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 12Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7) 2Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7) 3
(Date:8/6/2015)... Germany , August 6, 2015 ... (SMI) shows the world,s first Eye Tracking ... Epson,s Moverio BT-200 see-through head mounted display and on ... unprecedented quality and efficiency is brought to personalized visualization ... the first time, professionals and researchers can integrate gaze, ...
(Date:8/5/2015)... , Aug. 5, 2015 The biosensors market ... in applications, penetration into newer sectors, and development of ... global biosensors space has seen the entry of multiple ... so far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( ...
(Date:7/31/2015)... , Kina, 31. juli 2015 Den 10. ... afholdt af BGI fra den 22. - 25. oktober i ... Konferencen fejrer sin 10-års fødselsdag i år. Siden starten ... indflydelsesrige årlige møder på ,omik,-feltet, og er en af ... ICG-10 fokuserer på nylige gennembrud og fremskridt ...
Breaking Biology News(10 mins):SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
... A new study has found that the allergenicity of ... fermentation process. Researchers from North Carolina A&T University report ... the American Society for Microbiology. , "Due to the ... cookies, snacks and even soups there is a need ...
... viral-based therapies for cancer , Researchers at Columbia University ... to develop the next generation of effective viral-based therapies ... genetically engineered viruses studied in mice, published today in ... National Academy of Sciences (PNAS), bring us significantly closer ...
... have had an accelerated childhood compared to that of modern ... by researchers from Ohio State University and the University of ... tooth growth present in the Neanderthal fossils they examined was ... , And since the rate of tooth growth has ...
Cached Biology News:Columbia scientists develop cancer terminator viruses 2Columbia scientists develop cancer terminator viruses 3Neanderthal teeth grew no faster than comparable modern humans' 2Neanderthal teeth grew no faster than comparable modern humans' 3
... Science FLA-5100 imaging system allows imaging of ... 40 x 46cm at a pixel size ... is especially suitable for protein electrophoresis in ... for genomics., Fuji s FLA-5100 includes four ...
... speed and excellent temperature uniformity. Protocols that ... can be run without any modifications. The ... for 48 or 96 wells. In addition, ... applications are available. The High Precision Smart ...
... Workstation from Caliper represents a revolutionary breakthrough ... first time the ability to generate real-time ... changing conditions. In addition, each channel ... to changes in temperature, and offers its ...
... disposable microfiltration devices for the fast and reliable ... l to 500 l. They can be used ... tubes. Product Features: High-flux Polyethersulphonemembrane ... hold up volume ( Fast and reproducible performance ...
Biology Products: